Production (Stage)
Genelux Corporation
GNLX
$2.65
-$0.02-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.41% | 11.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.82% | 40.44% | |||
| Operating Income | 19.82% | -40.44% | |||
| Income Before Tax | 16.53% | -38.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.53% | -38.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.53% | -38.80% | |||
| EBIT | 19.82% | -40.44% | |||
| EBITDA | 19.96% | -40.76% | |||
| EPS Basic | 17.34% | -38.55% | |||
| Normalized Basic EPS | 17.32% | -38.63% | |||
| EPS Diluted | 17.34% | -38.55% | |||
| Normalized Diluted EPS | 17.32% | -38.63% | |||
| Average Basic Shares Outstanding | 0.98% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.98% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||